• Explore /
  • Poster
  • / Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study: A phase II study of cediranib in combination with olaparib in advanced solid tumors.

Abstract Video & Slides Poster

Authors

null

Joseph W. Kim

Yale Cancer Center, Yale School of Medicine, New Haven, CT

Joseph W. Kim , Navid Hafez , Hatem Hussein Soliman , Siqing Fu , Shumei Kato , Primo Lara Jr., Ulka N. Vaishampayan , Albiruni Ryan Abdul Razak , Dana Backlund Cardin , Pamela N. Munster , Joseph Paul Eder , Elizabeth M. Swisher , Andrew B. Nixon , Abhijit Patel , Yu Shyr , S. Percy Ivy , Patricia LoRusso

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02498613

Citation

J Clin Oncol 38: 2020 (suppl; abstr 9065)

DOI

10.1200/JCO.2020.38.15_suppl.9065

Abstract #

9065

Poster Bd #

258

Abstract Disclosures

Similar Posters

First Author: Navid Hafez

First Author: Joseph W. Kim

First Author: Ecaterina Elena Dumbrava

First Author: Joseph W. Kim